Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
An array of isoforms of the nuclear estrogen receptor alpha (ER-α) protein contribute to heterogeneous response in breast cancer (BCa); yet, a single-cell analysis tool that distinguishes the full-length ER-α66 protein from the activation function-1 deficient ER-α46 isoform has not been reported. Sp...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9775623135fe4148b38d349814c57b13 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9775623135fe4148b38d349814c57b13 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9775623135fe4148b38d349814c57b132021-12-02T20:06:24ZSingle-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.1932-620310.1371/journal.pone.0254783https://doaj.org/article/9775623135fe4148b38d349814c57b132021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254783https://doaj.org/toc/1932-6203An array of isoforms of the nuclear estrogen receptor alpha (ER-α) protein contribute to heterogeneous response in breast cancer (BCa); yet, a single-cell analysis tool that distinguishes the full-length ER-α66 protein from the activation function-1 deficient ER-α46 isoform has not been reported. Specific detection of protein isoforms is a gap in single-cell analysis tools, as the de facto standard immunoassay requires isoform-specific antibody probes. Consequently, to scrutinize hormone response heterogeneity among BCa tumor cells, we develop a precision tool to specifically measure ER-α66, ER- α46, and eight ER-signaling proteins with single-cell resolution in the highly hetero-clonal MCF-7 BCa cell line. With a literature-validated pan-ER immunoprobe, we distinguish ER-α66 from ER-α46 in each individual cell. We identify ER-α46 in 5.5% of hormone-sensitive (MCF-7) and 4.2% of hormone-insensitive (MDA-MB-231) BCa cell lines. To examine whether the single-cell immunoblotting can capture cellular responses to hormones, we treat cells with tamoxifen and identify different sub-populations of ER-α46: (i) ER-α46 induces phospho-AKT at Ser473, (ii) S6-ribosomal protein, an upstream ER target, activates both ER-α66 and ER-α46 in MCF-7 cells, and (iii) ER-α46 partitions MDA-MB-231 subpopulations, which are responsive to tamoxifen. Unlike other single-cell immunoassays, multiplexed single-cell immunoblotting reports-in the same cell-tamoxifen effects on ER signaling proteins and on distinct isoforms of the ER-α protein.John J KimWenchuan LiangChi-Chih KangMark D PegramAmy E HerrPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254783 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q John J Kim Wenchuan Liang Chi-Chih Kang Mark D Pegram Amy E Herr Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. |
description |
An array of isoforms of the nuclear estrogen receptor alpha (ER-α) protein contribute to heterogeneous response in breast cancer (BCa); yet, a single-cell analysis tool that distinguishes the full-length ER-α66 protein from the activation function-1 deficient ER-α46 isoform has not been reported. Specific detection of protein isoforms is a gap in single-cell analysis tools, as the de facto standard immunoassay requires isoform-specific antibody probes. Consequently, to scrutinize hormone response heterogeneity among BCa tumor cells, we develop a precision tool to specifically measure ER-α66, ER- α46, and eight ER-signaling proteins with single-cell resolution in the highly hetero-clonal MCF-7 BCa cell line. With a literature-validated pan-ER immunoprobe, we distinguish ER-α66 from ER-α46 in each individual cell. We identify ER-α46 in 5.5% of hormone-sensitive (MCF-7) and 4.2% of hormone-insensitive (MDA-MB-231) BCa cell lines. To examine whether the single-cell immunoblotting can capture cellular responses to hormones, we treat cells with tamoxifen and identify different sub-populations of ER-α46: (i) ER-α46 induces phospho-AKT at Ser473, (ii) S6-ribosomal protein, an upstream ER target, activates both ER-α66 and ER-α46 in MCF-7 cells, and (iii) ER-α46 partitions MDA-MB-231 subpopulations, which are responsive to tamoxifen. Unlike other single-cell immunoassays, multiplexed single-cell immunoblotting reports-in the same cell-tamoxifen effects on ER signaling proteins and on distinct isoforms of the ER-α protein. |
format |
article |
author |
John J Kim Wenchuan Liang Chi-Chih Kang Mark D Pegram Amy E Herr |
author_facet |
John J Kim Wenchuan Liang Chi-Chih Kang Mark D Pegram Amy E Herr |
author_sort |
John J Kim |
title |
Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. |
title_short |
Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. |
title_full |
Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. |
title_fullStr |
Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. |
title_full_unstemmed |
Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. |
title_sort |
single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/9775623135fe4148b38d349814c57b13 |
work_keys_str_mv |
AT johnjkim singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer AT wenchuanliang singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer AT chichihkang singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer AT markdpegram singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer AT amyeherr singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer |
_version_ |
1718375375251177472 |